Evidence map›Paper›PMID 38025736›Full record

ArticlePeerJ2023

Osmotic response during kidney perfusion with cryoprotectant in isotonic or hypotonic vehicle solution.

Ross M Warner, Jun Yang, Andrew Drake, Youngjoo Lee, Sarah Nemanic, David Scott, Adam Z Higgins

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ross M WarnerSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, Oregon, United States.ORCID 0000-0002-2650-937X
Jun YangSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, Oregon, United States.
Andrew DrakeSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, Oregon, United States.
Youngjoo LeeSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, Oregon, United States.
Sarah NemanicVeterinary Radiology Consulting LLC, Lebanon, Oregon, United States.
David ScottDepartment of Abdominal Transplantation, Oregon Health & Science University, Portland, Oregon, United States.
Adam Z HigginsSchool of Chemical, Biological, and Environmental Engineering, Oregon State University, Corvallis, Oregon, United States.
Oregon State University · USOregon Health & Science University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organ cryopreservation would revolutionize transplantation by overcoming the shelf-life limitations of conventional organ storage. To prepare an organ for cryopreservation, it is first perfused with cryoprotectants (CPAs). These chemicals can enable vitrification during cooling, preventing ice damage. However, CPAs can also cause toxicity and osmotic damage. It is a major challenge to find the optimal balance between protecting the cells from ice and avoiding CPA-induced damage. In this study, we examined the organ perfusion process to shed light on phenomena relevant to cryopreservation protocol design, including changes in organ size and vascular resistance. In particular, we compared perfusion of kidneys (porcine and human) with CPA in either hypotonic or isotonic vehicle solution. Our results demonstrate that CPA perfusion causes kidney mass changes consistent with the shrink-swell response observed in cells. This response was observed when the kidneys were relatively fresh, but disappeared after prolonged warm and/or cold ischemia. Perfusion with CPA in a hypotonic vehicle solution led to a significant increase in vascular resistance, suggesting reduced capillary diameter due to cell swelling. This could be reversed by switching to perfusion with CPA in isotonic vehicle solution. Hypotonic vehicle solution did not cause notable osmotic damage, as evidenced by low levels of lactate dehydrogenase (LDH) in the effluent, and it did not have a statistically significant effect on the delivery of CPA into the kidney, as assessed by computed tomography (CT). Overall, our results show that CPA vehicle solution tonicity affects organ size and vascular resistance, which may have important implications for cryopreservation protocol design.

Indexed as

CryopreservationIceAnimalsCryoprotective AgentsHumansHypotonic SolutionsKidneyPerfusionSwineCryoprotective AgentsHypotonic SolutionsIceComputed tomographyCryopreservationCryoprotectantKidneyLactate dehydrogenaseOrganOsmoticVascular resistanceVitrification

Identifiers

PMID38025736
PMCPMC10668850
OpenAlexW4388864647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.